Matinas Biopharma (MTNB) Profit Margin (2015 - 2023)
Matinas Biopharma (MTNB) profit margin from Mar 31, 2015 to Mar 31, 2023. The current Matinas Biopharma (MTNB) profit margin is -500.91%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Matinas Biopharma (MTNB)
| Year | Profit Margin | Change |
|---|---|---|
| 2023 | -2085.45% | +216.79% |
| 2022 | -658.31% | -99.15% |
| 2021 | -77600.00% | N/A |
| 2021 | -77600.00% | +453.05% |
| 2020 | -14031.25% | N/A |
| 2020 | -14031.25% | -27.30% |
| 2019 | -19300.00% | +64.49% |
| 2018 | -11733.33% | +13.62% |
| 2017 | -10326.67% | +114.67% |
| 2015 | -4810.53% | N/A |
Comparison Matinas Biopharma (MTNB) profit margin with competitors
Matinas Biopharma (MTNB) profit margin is -500.91%.